LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • February 17th, 2004 • Xcyte Therapies Inc • Pharmaceutical preparations • Washington
Contract Type FiledFebruary 17th, 2004 Company Industry JurisdictionThis License and Supply Agreement (“Agreement”) is entered into as of October 15th, 1999 (the “Effective Date”) by and between Xcyte Therapies, Inc., a Delaware corporation having a principal place of business at 2203 Airport Way South, Suite 300, Seattle, Washington 98134, United States (“Xcyte”), and Diaclone S.A., a French corporation having a principal place of business at 1 Boulevard Fleming, B.P. 1985 F-25020 Besancon Cedex, France (“Diaclone”).
LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • November 21st, 2003 • Xcyte Therapies Inc • Pharmaceutical preparations • Washington
Contract Type FiledNovember 21st, 2003 Company Industry JurisdictionThis License and Supply Agreement (“Agreement”) is entered into as of October 15th, 1999 (the “Effective Date”) by and between Xcyte Therapies, Inc., a Delaware corporation having a principal place of business at 2203 Airport Way South, Suite 300, Seattle, Washington 98134, United States (“Xcyte”), and Diaclone S.A., a French corporation having a principal place of business at 1 Boulevard Fleming, B.P. 1985 F-25020 Besancon Cedex, France (“Diaclone”).